LPS receptor (CD14): A receptor for phagocytosis of Alzheimer's amyloid peptide

Brain

Volumn 128, Issue 8, 2005, Pages 1778-1789

  Liu, Yang ^a   Walter, Silke ^a   Stagi, Massimiliano ^a   Cherny, Dmitry ^d,e   Letiembre, Maryse ^a   Schulz Schaeffer, Walter ^a   Heine, Holger ^b   Penke, Botond ^f   Neumann, Harald ^a   Fassbender, Klaus ^a,c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

^f UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Alzheimer's disease; Amyloid protein; CD14; Microglia; Phagocytosis

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN; CD14 ANTIGEN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN; CHO CELL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; MOLECULAR DYNAMICS; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL; ANIMAL; BIOTINYLATION; C57BL MOUSE; CRICETULUS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETICS; HAMSTER; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METHODOLOGY; MICROGLIA; MOUSE; POLYMERASE CHAIN REACTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIGENS, CD14; BIOTINYLATION; BRAIN; CHO CELLS; CRICETINAE; CRICETULUS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICROGLIA; MICROSCOPY, CONFOCAL; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 23444448277     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awh531     Document Type: Article

References (46)

1. Aderem A. Phagocytosis and the inflammatory response. J Infect Dis 2003; 187 Suppl 2: S340-5.
2. Akiyama H, McGeer PL. Specificity of mechanisms for plaque removal after Aβ immunotherapy for Alzheimer disease. Nat Med 2004; 10: 117-8.
3. Arends YM, Duyckaerts C, Rozemuller JM, Eikelenboom P, Hauw JJ. Microglia, amyloid and dementia in Alzheimer's disease. A correlative study. Neurobiol Aging 2000; 21: 39-47.
4. Bacskai BJ, Skoch J, Hickey GA, Allen R, Hyman BT. Fluorescence resonance energy transfer determinations using multiphoton fluorescence lifetime imaging microscopy to characterize amyloid-beta plaques. J Biomed Optics 2003; 8: 368-75.
5. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000; 6: 916-9.
6. Bate C, Veerhuis R, Eikelenboom P, Williams A. Microglia kill amyloid-beta1-42 damaged neurons by a CD14-dependent process. Neuroreport 2004; 15: 1427-30.
7. Blander JM, Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. Science 2004; 304: 1014-18.
8. Bocharov AV, Baranova IN, Vishnyakova TG, Remaley AT, Csako G, Thomas F, et al. Targeting of scavenger receptor class B type I by synthetic amphipathic alpha-helical-containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-inflammatory cytokine responses in THP-1 monocyte cells. J Biol Chem 2004; 279: 36072-82.
9. Borchardt T, Camakaris J, Cappai R, Masters CL, Beyreuther K, Multhaup G. Copper inhibits β-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. Biochem J. 1999; 344 Pt 2: 461-7.
10. Check E. Nerve inflammation halts trial for Alzheimer's drug. Nature 2002; 415: 462.
11. Chen JW, Murphy TL, Willingham MC, Pastan I, August JT. Identification of two lysosome membrane glycoproteins. J Cell Biol 1985; 101: 85-95.
12. Citron M. Alzheimer's disease: treatments in discovery and development. Nat Neurosci 2002; 5 Suppl: 1055-7.
13. Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 2002; 277: 32046-53.
14. Das P, Howard V, Loosbrock N, Dickson D, Murphy MP, Golde TE. Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice. J Neurosci 2003; 23: 8532-8.
15. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998; 392: 505-9.
16. Eikelenboom P, Veerhuis R. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol Aging 1996; 17: 673-80.
17. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, et al. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Aβ 42 and Aβ 40 in vitro and in vivo. Proc Natl Acad Sci USA 2001; 98: 5856-61.
18. Fassbender K, Walter S, Kuhl S, Landmann R, Ishii K, Bertsch T, et al. The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J 2004; 18: 203-5.
19. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 1995; 373: 523-7.
20. Golenbock DT, Liu Y, Millham FH, Freeman MW, Zoeller RA. Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. J Biol Chem 1993; 268: 22055-9.
21. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4: 407-14.
22. Hoyer W, Antony T, Cherny D, Heim G, Jovin TM, Subramaniam V. Dependence of alpha-synuclein aggregate morphology on solution conditions. J Mol Biol 2002; 322: 383-93.
23. Huang F, Buttini M, Wyss-Coray T, McConlogue L, Kodama T, Pitas RE, et al. Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors. Am J Pathol 1999; 155: 1741-47.
24. Ishii K, Muelhauser F, Liebl U, Picard M, Kuhl S, Penke B, et al. Subacute NO generation induced by Alzheimer's beta-amyloid in the living brain: reversal by inhibition of the inducible NO synthase. FASEB J 2000; 14: 1485-9.
25. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol. 1989; 24: 173-82.
26. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000; 408: 979-82.
27. Katoh S, Zheng Z, Oritani K, Shimozato T, Kincade PW. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J Exp Med 1995; 182: 419-9.
28. Le Cabec V, Carreno S, Moisand A, Bordier C, Maridonneau-Parini I. Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively. J Immunol 2002; 169: 2003-9.
29. Lipovsky MM, Gekker G, Anderson WR, Molitor TW, Peterson PK, Hoepelman AI. Phagocytosis of nonopsonized Cryptococcus neoformans by swine microglia involves CD14 receptors. Clin Immunol Immunopathol 1997; 84: 208-11.
30. McGeer EG, McGeer PL. Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 741-9.
31. Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, et al. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995; 374: 647-50.
32. Mimura N, Asano A. Synergistic effect of colchicine and cytochalasin D on phagocytosis by peritoneal macrophages. Nature 1976; 261: 319-21.
33. Moore KJ, Andersson LP, Ingalls RR, Monks BG, Li R, Arnaout MA, et al. Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol 2000; 165: 4272-80.
34. Muro M, Koseki T, Akifusa S, Kato S, Kowashi Y, Ohsaki Y, et al. Role of CD14 molecules in internalization of Actinobacillus actinomycetemcomitans by macrophages and subsequent induction of apoptosis. Infect Immun 1997; 65: 1147-51.
35. Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 2003; 9: 448-52.
36. Paresce DM, Ghosh RN, Maxfield FR. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 1996; 17: 553-65.
37. Peterson PK, Gekker G, Hu S, Sheng WS, Anderson WR, Ulevitch RJ, et al. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect Immun 1995; 63: 1598-602.
38. Poussin C, Foti M, Carpentier JL, Pugin J. CD14-dependent endotoxin internalization via a macropinocytic pathway. J Biol Chem 1998; 273: 20285-91.
39. Ravetch JV, Clynes RA. Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 1998; 16: 421-32.
40. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173-7.
41. Schmitz G, Orso E. CD14 signalling in lipid rafts: new ligands and co-receptors. Curr Opin Lipidol 2002; 13: 513-21.
42. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997; 94: 13287-92.
43. Stryer L. Fluorescence Energy Transfer as a Spectroscopic Ruler. Ann Rev Biochem 1978; 17: 819-46.
44. Vasselon T, Hailman E, Thieringer R, Detmers PA. Internalization of monomeric lipopolysaccharide occurs after transfer out of cell surface CD14. J Exp Med 1999; 190: 509-21.
45. Wyss-Coray T, Yan F, Lin AH, Lambris JD, Alexander JJ, Quigg RJ, et al. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci USA 2002; 99: 10837-42.
46. Yazawa H, Yu ZX, Takeda, Le Y, Gong W, Ferrans VJ, et al. Beta amyloid peptide (Aβ42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J 2001; 15: 2454-62.